Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo

[1] Herrington W(2016)Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease Circ Res 118 535-546

[2] Lacey B(2020)Improving prevention strategies for cardiometabolic disease Nat Med 26 320-325

[3] Sherliker P(2019)Comparing the Risk Factors of Plaque Rupture and Failed Plaque Healing in Acute Coronary Syndrome JAMA Cardiol 4 329-331

[4] Armitage J(2014)Comprehensive plaque assessment by coronary CT angiography Nat Rev Cardiol 11 390-402

[5] Lewington S(2005)Atherothrombosis and high-risk plaque: part I: evolving concepts J Am Coll Cardiol 46 937-954

[6] Sattar N(2007)Plaque neovascularization and antiangiogenic therapy for atherosclerosis J Am Coll Cardiol 49 2073-2080

[7] Gill JMR(2006)Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E Endothelium 13 63-69

[8] Alazawi W(2012)Plaque rupture complications in murine atherosclerotic vein grafts can be prevented by TIMP-1 overexpression PLoS One 7 e47134-40

[9] Brezinski ME(2018)Axitinib attenuates intraplaque angiogenesis, haemorrhages and plaque destabilization in mice Vascul Pharmacol 100 34-103

[10] Maurovich-Horvat P(2003)Targeted Circulation 108 97-509

[1] Herrington W(2016)Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease Circ Res 118 535-546

[2] Lacey B(2020)Improving prevention strategies for cardiometabolic disease Nat Med 26 320-325

[3] Sherliker P(2019)Comparing the Risk Factors of Plaque Rupture and Failed Plaque Healing in Acute Coronary Syndrome JAMA Cardiol 4 329-331

[4] Armitage J(2014)Comprehensive plaque assessment by coronary CT angiography Nat Rev Cardiol 11 390-402

[5] Lewington S(2005)Atherothrombosis and high-risk plaque: part I: evolving concepts J Am Coll Cardiol 46 937-954

[6] Sattar N(2007)Plaque neovascularization and antiangiogenic therapy for atherosclerosis J Am Coll Cardiol 49 2073-2080

[7] Gill JMR(2006)Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E Endothelium 13 63-69

[8] Alazawi W(2012)Plaque rupture complications in murine atherosclerotic vein grafts can be prevented by TIMP-1 overexpression PLoS One 7 e47134-40

[9] Brezinski ME(2018)Axitinib attenuates intraplaque angiogenesis, haemorrhages and plaque destabilization in mice Vascul Pharmacol 100 34-103

[10] Maurovich-Horvat P(2003)Targeted Circulation 108 97-509